Ozempic doesn’t actually have a weight requirement. It’s FDA-approved for type 2 diabetes, not weight loss, so the qualifying factor is your blood sugar, not your BMI. If you’re looking for semaglutide specifically for weight management, the version approved for that purpose is Wegovy, which requires a BMI of 30 or higher, or a BMI of 27 or higher if you also have a weight-related health condition like high blood pressure, high cholesterol, or type 2 diabetes.
That distinction matters because it shapes what your doctor can prescribe, what insurance will cover, and what dose you’ll receive. Here’s how the whole picture breaks down.
Ozempic Is Not Approved for Weight Loss
Ozempic and Wegovy contain the same active ingredient, semaglutide, but they’re approved for different purposes. Ozempic is indicated for adults with type 2 diabetes to improve blood sugar control, reduce cardiovascular risk, and protect kidney function. There is no BMI cutoff in its prescribing label. If you have type 2 diabetes, your doctor can prescribe Ozempic regardless of your weight.
Weight loss happens as a side effect for many people on Ozempic, and that’s driven enormous off-label demand. Some doctors do prescribe it off-label for weight management, but when they do, they’re working outside the drug’s official indication. That creates complications with insurance coverage and sometimes with supply for people who need it for diabetes.
Wegovy’s BMI Thresholds
Wegovy is the semaglutide product the FDA has approved specifically for chronic weight management. The requirements are straightforward:
- BMI of 30 or higher (classified as obesity), with no additional conditions needed
- BMI of 27 to 29.9 (classified as overweight), plus at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia (abnormal cholesterol or triglyceride levels)
For reference, a BMI of 27 works out to roughly 180 pounds for someone 5’7″, or 195 pounds for someone 5’10”. A BMI of 30 would be about 195 pounds at 5’7″ or 210 pounds at 5’10”. You can calculate your own BMI by dividing your weight in pounds by your height in inches squared, then multiplying by 703.
Wegovy is also approved for cardiovascular risk reduction in adults who have obesity or overweight along with established heart disease, and for treatment of a specific liver condition called metabolic dysfunction-associated steatohepatitis (MASH) with moderate or advanced scarring.
What Insurance Actually Requires
Meeting the FDA thresholds doesn’t guarantee your insurance will pay. Many insurers layer on additional requirements through a process called prior authorization. The specifics vary widely by plan, but common patterns include requiring documented proof of your BMI, evidence that you’ve tried diet and exercise changes, and sometimes proof that you’ve tried other weight-loss approaches first.
Some state Medicaid programs don’t cover semaglutide for weight loss at all. Washington State’s Medicaid program, for example, only covers Wegovy for patients who have established cardiovascular disease (prior heart attack, stroke, or documented artery disease) along with a BMI of 27 or higher. Simply meeting the FDA’s obesity threshold wouldn’t be enough to get coverage under that plan.
Private insurance varies just as much. Some commercial plans cover Wegovy with a straightforward prior authorization. Others exclude weight-management drugs entirely. If your plan denies coverage, your doctor’s office can often submit an appeal with clinical documentation, but there’s no guarantee. Out-of-pocket costs without insurance run over $1,000 per month for brand-name semaglutide.
Off-Label Ozempic for Weight Loss
When doctors prescribe Ozempic off-label for weight loss, they generally follow the same BMI thresholds used for Wegovy: 30 and above, or 27 and above with a related health condition. This isn’t a regulatory requirement for Ozempic itself, but it reflects established clinical standards for when weight-loss medication is appropriate.
There are practical differences between the two drugs, though. Ozempic’s maximum dose is 2 mg per week, while Wegovy goes up to 2.4 mg per week. Both start at a low dose and gradually increase over several weeks to reduce side effects, primarily nausea. Ozempic typically starts at 0.25 mg weekly for four weeks, then moves to 0.5 mg, with the option to increase further. Wegovy follows a similar but longer titration to reach its higher maintenance dose.
In clinical trials of people with type 2 diabetes, the 2 mg dose of semaglutide produced an average weight loss of about 6.9 kilograms (roughly 15 pounds) over 40 weeks. Trials of the higher Wegovy dose in people without diabetes have shown larger average losses, in the range of 12 to 15 percent of body weight.
How BMI Categories Are Defined
BMI categories are standardized by the World Health Organization and used by nearly all clinical guidelines:
- Overweight: BMI 25 to 29.9
- Class 1 obesity: BMI 30 to 34.9
- Class 2 obesity: BMI 35 to 39.9
- Class 3 obesity: BMI 40 or higher
BMI is a rough screening tool, not a perfect measure of health. It doesn’t account for muscle mass, bone density, or where you carry fat. Someone with a BMI of 28 who has high blood pressure and prediabetes may benefit more from treatment than someone with a BMI of 32 and no metabolic issues. That’s partly why the guidelines include that lower threshold of 27 for people with comorbidities.
What to Expect at Your Appointment
If you’re considering semaglutide for weight loss, your doctor will likely measure your height and weight to calculate your BMI, review your medical history for qualifying conditions, and check your blood sugar to rule out (or confirm) type 2 diabetes. If you do have type 2 diabetes, Ozempic becomes a straightforward on-label option, and the conversation shifts to blood sugar management with weight loss as an expected benefit.
If you don’t have diabetes and want semaglutide purely for weight management, your doctor would typically prescribe Wegovy rather than Ozempic. Be prepared for the possibility that your insurance requires prior authorization, which can add a few days to a few weeks before you fill the prescription. Your doctor’s office handles most of the paperwork, but you may need to provide records of previous weight-loss attempts depending on your plan’s requirements.